Monitoring of NOAC Therapy: Standardizing Reference Intervals
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Ischemic
- Ischemic Stroke
- Stroke Syndrome
- Stroke Acute
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
360 patients who are on dabigatran, apixaban and rivaroxaban based on the above inclusion and exclusion criteria will be recruited. After the informed consent, the patient will be needed for blood taking before and 2 hours after the medication (NOAC). The patient's demographic data and medical histo...
360 patients who are on dabigatran, apixaban and rivaroxaban based on the above inclusion and exclusion criteria will be recruited. After the informed consent, the patient will be needed for blood taking before and 2 hours after the medication (NOAC). The patient's demographic data and medical history will also be retreived from Central Medical Syetem too.
Tracking Information
- NCT #
- NCT04611893
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Yiu Ming Bonaventure IP, MRCP Chinese University of Hong Kong
Get Well Soon